Publikationen, an denen er mitarbeitet ENRIQUE BLÁZQUEZ FERNÁNDEZ (31)

2022

  1. Glucose and Several Mitogenic Agents Modulate the Glucagon-Like Peptide-2 Receptor Expression in Cultured Rat Astrocytes

    Journal of Alzheimer's Disease Reports, Vol. 6, Núm. 1, pp. 723-732

  2. Significance of Brain Glucose Hypometabolism, Altered Insulin Signal Transduction, and Insulin Resistance in Several Neurological Diseases

    Frontiers in Endocrinology, Vol. 13

2014

  1. Insulin in the brain: Its pathophysiological implications for states related with central insulin resistance, type 2 diabetes and alzheimer's disease

    Frontiers in Endocrinology, Vol. 5, Núm. OCT

2012

  1. Glucagon-like peptide-2 (GLP-2) modulates the cGMP signalling pathway by regulating the expression of the soluble guanylyl cyclase receptor subunits in cultured rat astrocytes

    Molecular Neurobiology, Vol. 46, Núm. 2, pp. 242-250

2010

  1. Signaling and biological effects of glucagon-like peptide 1 on the differentiation of mesenchymal stem cells from human bone marrow

    American Journal of Physiology - Endocrinology and Metabolism, Vol. 298, Núm. 3

2009

  1. Synergistic effect of glucagon-like peptide 2 (GLP-2) and of key growth factors on the proliferation of cultured rat astrocytes. Evidence for reciprocal upregulation of the mRNAs for GLP-2 and IGF-I receptors

    Molecular Neurobiology, Vol. 40, Núm. 2, pp. 183-193

2008

  1. Leptin but not neuropeptide Y up-regulated glucagon-like peptide 1 receptor expression in GT1-7 cells and rat hypothalamic slices

    Metabolism: Clinical and Experimental, Vol. 57, Núm. 1, pp. 40-48

2007

  1. Effects of glucose and insulin on glucokinase activity in rat hypothalamus

    Journal of Endocrinology, Vol. 193, Núm. 2, pp. 259-267

  2. Functional analysis of human glucokinase gene mutations causing MODY2: exploring the regulatory mechanisms of glucokinase activity.

    Diabetologia, Vol. 50, Núm. 2, pp. 325-333

2006

  1. 25-Hydroxycholesterol has a dual effect on the proliferation of cultured rat astrocytes

    Neuropharmacology, Vol. 51, Núm. 2, pp. 229-237

  2. Effects of novel maturity-onset diabetes of the young (MODY)-associated mutations on glucokinase activity and protein stability

    Biochemical Journal, Vol. 393, Núm. 1, pp. 389-396

  3. Gene symbol: GCK. Disease: diabetes, MODY.

    Human genetics, Vol. 119, Núm. 3, pp. 363

2005

  1. Aspectos moleculares de la diabetes tipo mody

    Fundamentos moleculares de la medicina (Real Academia Nacional de Medicina), pp. 163-174

  2. Fundamentos moleculares de los mecanismos de acción de la insulina

    Fundamentos moleculares de la medicina (Real Academia Nacional de Medicina), pp. 135-146

  3. Substitution of the cysteine 438 residue in the cytoplasmic tail of the glucagon-like peptide-1 receptor alters signal transduction activity

    Journal of Endocrinology, Vol. 185, Núm. 1, pp. 35-44

  4. The cytoplasmic domain close to the transmembrane region of the glucagon-like peptide-1 receptor contains sequence elements that regulate agonist-dependent internalisation

    Journal of Endocrinology, Vol. 186, Núm. 1, pp. 221-231

2003

  1. Glucagon-like peptide-2 stimulates the proliferation of cultured rat astrocytes

    European Journal of Biochemistry, Vol. 270, Núm. 14, pp. 3001-3009

2002

  1. Evidence that glucokinase regulatory protein is expressed and interacts with glucokinase in rat brain

    Journal of Neurochemistry, Vol. 80, Núm. 1, pp. 45-53

  2. Expression of glucose transporter-2, glucokinase and mitochondrial glycerolphosphate dehydrogenase in pancreatic islets during rat ontogenesis

    European Journal of Biochemistry, Vol. 269, Núm. 1, pp. 119-127

2001

  1. Effects of triiodothyronine and bovine growth hormone on glucose transporter isoform-2 (GLUT-2) and glucokinase (GK) gene expression in pancreatic islets of fetal and adult rats

    Pflugers Archiv European Journal of Physiology, Vol. 442, Núm. 5, pp. 662-667